Skip to main content
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.080
+0.330 (8.80%)
At close: Mar 9, 2026, 4:00 PM EDT
4.070
-0.010 (-0.25%)
After-hours: Mar 9, 2026, 7:07 PM EDT

Whitehawk Therapeutics Revenue

Whitehawk Therapeutics had revenue of $14.38M in the twelve months ending September 30, 2025, down -42.62% year-over-year. In the year 2024, Whitehawk Therapeutics had annual revenue of $25.98M with 6.69% growth.

Revenue (ttm)
$14.38M
Revenue Growth
-42.62%
P/S Ratio
13.37
Revenue / Employee
$653,818
Employees
22
Market Cap
192.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M13.83M1,846.60%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Vaxart 148.20M
Caribou Biosciences 11.16M
Tonix Pharmaceuticals Holding 10.30M
Cartesian Therapeutics 1.09M
Molecular Partners AG 856.30K
SAB Biotherapeutics 114.70K
Revenue Rankings

WHWK News

More News